Precision medicine has emerged as a game-changer, revolutionizing the landscape of clinical trials and offering new hope for advancement of critical medicines. However, the intricate nature of precision medicine requires precision-based solutions for trial sponsors, clinical research organizations (CROs), labs, and research sites....
The Blue Ridge Institute for Medical Research (BRIMR) has listed the University of Wisconsin Department of Medicine as 12th in the nation for departments of internal medicine receiving research funding from the National Institutes of Health (NIH) in 2023....
The ongoing effort to make Wisconsin a nationally recognized technology hub could get a $7.5 million boost from state funds following the passage of a bill designed to help Wisconsin compete for up to $70 million in federal funds. ...
2024 is a critical year for professionals throughout the clinical research enterprise to build on the momentum gained in 2023 for improving diversity, equity, and inclusion (DEI) among clinical trials participants and other stakeholders. ...
The US Food and Drug Administration (FDA) is focusing on how artificial intelligence (AI) can be used to support clinical trials but says it will take time to get there....
At the Universities of Wisconsin Board of Regents meeting on Friday, Feb. 9, experts gathered to discuss the university’s strategy for maximizing federal funding through burgeoning public-private partnerships, a crucial component of the national push for innovation and economic development....
Construction work is on schedule at UW Health Eastpark Medical Center, with a plan to begin seeing patients on Oct. 28....
The University of Wisconsin—Madison will build on its 175 years of excellence with several bold new initiatives designed to address global challenges, notably artificial intelligence and environmental sustainability....
A new Health Link security offering for principal investigators will grant additional research security similar to what is currently provided to research coordinators....
The US Food and Drug Administration (FDA) is outlining a standardized approach for collecting and reporting on race and ethnicity data in clinical trials and studies in a new draft guidance document....
